REVIEW PAPER
Interdisciplinary dental care as a component of comprehensive treatment for patients with cystic fibrosis
1
Department of Dental Traumatology, Chair of Pediatric Dentistry, Poznan University of Medical Sciences, Poznan, Poland
Submission date: 2024-11-04
Final revision date: 2025-05-04
Acceptance date: 2025-05-25
Publication date: 2026-06-29
Corresponding author
Tamara Pawlaczyk-Kamieńska
Department of Dental Traumatology Chair of Pediatric Dentistry Poznan University of Medical Sciences Poznan, Poland
Department of Dental Traumatology Chair of Pediatric Dentistry Poznan University of Medical Sciences Poznan, Poland
Medical Studies 2026;42(2):157-162
KEYWORDS
TOPICS
ABSTRACT
This paper aims to identify the dental prevention and treatment needs of patients with cystic fibrosis (CF) and suggest implementation of dedicated dental health standards for such patients. Oral bacterial microbiota are a part of the upper respiratory tract microbiota, which is of crucial importance, especially for patients at risk of respiratory auto-infection. Parents and, later, patients themselves are not always aware of the harmful impact of the ongoing pathologies in the oral cavity on the whole body. Hence, educating on how to counteract auto-infection is necessary. CF patients are a group that require targeted dental care, and a dentist should be a member of a multi-specialist patient-care team. To improve the oral health of CF patients, it is advisable to implement overall solutions involving targeted preventive and therapeutic measures. Presented oral health standards of CF patients may affect their general health and quality of life.
REFERENCES (32)
1.
Southern KW, Munck A, Pollitt R, Travert G, Zanolla L, Dankert-Roelse J, Castellani C. ECFS CF Neonatal Screening Working Group. A survey of newborn screening for cystic fibrosis in Europe. J Cyst Fibros. 2007; 6: 57-65.
2.
Sand D. (ed). Opieka nad chorym na mukowiscydozę w Polsce. Stan obecny i rekomendacje poprawy. Raport 2019. doi: ptwm.org.pl/assets/file/501,raport_druk.pdf.
3.
Farrell PM. The prevalence of cystic fibrosis in the European Union. J Cyst Fibros. 2008; 7(5): 450-453.
4.
Davies J, Alton E, Griesenbach U. Cystic fibrosis modifier genes. J R Soc Med. 2005; 98: 47-54.
6.
Arquitt CK, Boyd C, Wright JT. Cystic fibrosis transmembrane regulator gene (CFTR) is associated with abnormal enamel formation. J Dent Res. 2002; 81: 492-496.
7.
Bronckers A, Kalogeraki L, Jorna Hjn, Wilke M, Bervoets TI, Lyaruu DM, Zandieh-Doulabi B, Denbesten P, De Jonge H. The cystic fibrosis transmembrane conductance regulator (CFTR) is expressed in maturation stage ameloblasts, odontoblasts and bone cells. Bone. 2010; 46: 1188-1196.
8.
Chang EH, Lacruz RS, Bromage TG, Bringas P Jr, Welsh MJ, Zabner J, Paine ML. Enamel pathology resulting from loss of function in the cystic fibrosis transmembrane conductance regulator in a porcine animal model. Cells Tissues Organs. 2011; 194: 249-254.
9.
Saint-Criq V, Gray MA. Role of CFTR in epithelial physiology. Cell Mol Life Sci. 2017; 74: 93-115.
10.
Pawlaczyk-Kamieńska T, Borysewicz-Lewicka M, Śniata- ła R, Batura-Gabryel H, Cofta S. Dental and periodontal manifestations in patients with cystic fibrosis - a systematic review. J Cyst Fibros. 2019; 18: 762-771.
11.
Petersen PE, Bourgeois D, Ogawa H, Estupinan-Day S, Ndiaye C. The global burden of oral diseases and risks to oral health. Bull World Health Organ. 2005; 83: 661-669.
12.
Pawlaczyk-Kamieńska T, Borysewicz-Lewicka M, Batura-Gabryel H. Salivary biomarkers and oral microbial load in relation to the dental status of adults with cystic fibrosis. Mocroorganisms. 2019; 7(12): 692.
13.
Martens LC, Aps JKM, Van Maele GO. Is oral health at risk in people with cystic fibrosis? Eur J Paediatr Dent. 2001; 2: 21-27.
14.
Peker S, Kargul B, Tanboga I, Tunali-Akbay T, Yarat A, Karakoc F, Ersu R, Dagli E. Oral health and related factors in a group of children with cystic fibrosis in Istanbul, Turkey. Niger J Clin Pract. 2015; 18: 56-60.
15.
Pawlaczyk-Kamieńska T, Borysewicz-Lewicka M, Śniata- ła R. Periodontal condition and periodontal risk assessment in adult patients with cystic fibrosis. Ann Agric Environ Med. 2020; 27(2): 235-239.
16.
Pawlaczyk-Kamieńska T, Borysewicz-Lewicka M. Dental bacterial biofilm and gingival status in cystic fibrosis adult patients. Postepy Hig Med Dosw. 2021; 75: 101-106.
17.
Pawlaczyk-Kamieńska T. Oral health status and influential risk factors in cystic fibrosis patients. Post Biol Komórki. 2020; 47(2): 197-207.
18.
Zinn VZ, Khatri A, Mednieks MJ, Hand AR. Localization of CFTR signaling complexes in human salivary gland striated duct cells. Eur J Oral Sci. 2015; 123: 140-148.
19.
Shin YH, Lee SW, Kim M, Choi SY, Cong X, Yu GY, Park K. Epigenetic regulation of CFTR in salivary gland. Biochem Biophys Res Commun. 2016; 481: 31-37.
20.
Aps JK, Delanghe J, Martens LC. Salivary electrolyte concentrations are associated with cystic fibrosis transmembrane regulator genotypes. Clin Chem Lab Med. 2002; 40: 345-350.
21.
Ferrazzano GF, Orlando S, Sangianantoni G, Cantile T, Ingenito A. Dental and periodontal health status in children affected by cystic fibrosis in a southern Italian region. Eur J Paediatr Dent. 2009; 10: 65-68.
22.
Peker S, Mete S, Gokdemir Y, Karadag B, Kargul B. Related factors of dental caries and molar incisor hypomineralisation in a group of children with cystic fibrosis. Eur Arch Paediatr Dent. 2014; 15: 275-280.
23.
Sui W, Boyd C, Wright JT. Altered pH regulation during enamel development in the cystic fibrosis mouse incisor. J Dent Res. 2003; 82: 388-392.
24.
Pawlaczyk-Kamieńska T, Borysewicz-Lewicka M, Śniatała R, Batura-Gabryel H. Clinical evaluation of the dental hard tissues in an adult population with cystic fibrosis. Pol Arch Intern Med. 2019, 129: 725-727.
25.
Lacruz RS, Nanci A, Kurtz I, Wright JT, Paine MI. Regulation of pH during amelogenesis. Calcif Tissue Int. 2010; 86: 91-103.
26.
Bronckers ALJJ, Lyaruu DM, Guo J, Bijvelds MJC, Ber- voets TJM, Zandieh-Doulabi B, Medina JF, Li Z, Zhang Y, DenBesten PK. Composition of mineralizing incisor enamel in CFTR-deficient mice. Eur J Oral Sci. 2015; 123: 9-16.
27.
Narang A, Maguire A, Nunn J, Bush A. Oral health and related factors in cystic fibrosis and other chronic respiratory disorders. Arch Dis Child. 2003; 88: 702-707.
29.
Pawlaczyk-Kamieńska T, Śniatała R, Batura-Gabryel H, Borysewicz-Lewicka M, Cofta S. Periodontal status and subgingival biofilms in cystic fibrosis adults. Pol J Microbiol. 2019, 68: 377-382.
30.
American Academy of Pediatric Dentistry. Perinatal and infant oral health care. The Reference Manual of Pediatric Dentistry. Chicago, Ill.: American Academy of Pediatric Dentistry; 2021; 262-266.
31.
American Academy of Pediatric Dentistry: Guideline on infant oral health care. Pediatr Dent 2014; 36(6(1)): 1141-1145.
32.
American Dental Association. Statement on early childhood caries. http://www.ada. org/en/about-the-ada/ada-positions-policies-and-statements/statement-on-earlychildhood-caries.
| eISSN: | 2300-6722 |
| ISSN: | 1899-1874 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
